ANKRD1通过激活NF-κB-MAGE-A6通路促进乳腺癌转移
Penchatr Diskul-Na-Ayudthaya1,2, Seon Joo Bae1, Yun-Ui Bae3
1Soonchunhyang Institute of Medi-bio Science (SIMS), Department of Integrated Biomedical Sciences, Soonchunhyang University, Asan-si 31151, Republic of Korea.
Cancers
|October 16, 2024
概括
这项研究确定ANKRD1是乳腺癌转移的关键驱动因素. 高水平的ANKRD1通过激活NF-κB和MAGE-A6通路来促进癌细胞迁移和入侵,这表明它是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 乳腺癌的生存率通过早期检测和手术改善.
- 转移性乳腺癌患者面临着不良的预后.
- 在转移中NF-κB和MAGE-A6的上游调节者尚不清楚.
研究的目的:
- 研究ANKRD1在乳腺癌转移中的作用.
- 探索ANKRD1作为治疗标和诊断标记物的潜力.
主要方法:
- 在转移性与非转移性乳腺癌细胞系和瘤等级中比较ANKRD1表达.
- 对ANKRD1.1进行了体外和体内功能研究.
- 研究了ANKRD1对NF-κB和MAGE-A6信号传递的影响.
主要成果:
- 在转移性乳腺癌细胞系和高度瘤中,ANKRD1的表达很高.
- ANKRD1促进癌细胞的迁移和入侵.
- ANKRD1可以激活NF-κB和MAGE-A6信号通路.
结论:
- ANKRD1通过激活NF-κB和MAGE-A6.1促进乳腺癌转移.
- ANKRD1 是乳腺癌转移的潜在治疗标.
- ANKRD1可以作为乳腺癌转移的诊断标志物.
相关概念视频
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K


